Calip GS - Search Results

1

Serious opioid-related adverse outcomes associated with opioids prescribed by dentists.

Khouja T, Zhou J, Gellad WF, Mitsantisuk K, Hubbard CC, Yan CH, Sharp LK, Calip GS, Evans CT, Suda KJ. Khouja T, et al. Among authors: calip gs. Pain. 2022 Aug 1;163(8):1571-1580. doi: 10.1097/j.pain.0000000000002545. Epub 2021 Nov 25. Pain. 2022. PMID: 35838648 Free PMC article.

2

Prognostic value of translocation 11;14 in patients with relapsed/refractory myeloma receiving anti-CD38 therapy.

Mohyuddin GR, Chakraborty R, Calip GS, Ascha MS, Wang X, Rubinstein SM, Tuchman S, Costa L, Haaland B, Giri S, Mian H, Fonseca R, Sborov D. Mohyuddin GR, et al. Among authors: calip gs. Blood Cancer J. 2022 Dec 16;12(12):168. doi: 10.1038/s41408-022-00769-4. Blood Cancer J. 2022. PMID: 36526617 Free PMC article. No abstract available.

3

End-of-Life Systemic Oncologic Treatment in the Immunotherapy Era: The Role of Race, Insurance, and Practice Setting.

Canavan M, Wang X, Ascha M, Miksad R, Showalter TN, Calip G, Gross CP, Adelson K. Canavan M, et al. J Clin Oncol. 2023 Oct 20;41(30):4729-4738. doi: 10.1200/JCO.22.02180. Epub 2023 Jun 20. J Clin Oncol. 2023. PMID: 37339389

4

Top-down Versus Step-up Prescribing Strategies for Tumor Necrosis Factor Alpha Inhibitors in Children and Young Adults with Inflammatory Bowel Disease.

Lee WJ, Briars L, Lee TA, Calip GS, Suda KJ, Schumock GT. Lee WJ, et al. Among authors: calip gs. Inflamm Bowel Dis. 2016 Oct;22(10):2410-7. doi: 10.1097/MIB.0000000000000880. Inflamm Bowel Dis. 2016. PMID: 27537053

5

Use of Tumor Necrosis Factor-Alpha Inhibitors in Children and Young Adults With Juvenile Idiopathic Arthritis or Rheumatoid Arthritis.

Lee WJ, Briars L, Lee TA, Calip GS, Suda KJ, Schumock GT. Lee WJ, et al. Among authors: calip gs. Pharmacotherapy. 2016 Dec;36(12):1201-1209. doi: 10.1002/phar.1856. Epub 2016 Dec 4. Pharmacotherapy. 2016. PMID: 27779782

6

Risk of serious bacterial infection associated with tumour necrosis factor-alpha inhibitors in children with juvenile idiopathic arthritis.

Lee WJ, Lee TA, Suda KJ, Calip GS, Briars L, Schumock GT. Lee WJ, et al. Among authors: calip gs. Rheumatology (Oxford). 2018 Feb 1;57(2):273-282. doi: 10.1093/rheumatology/kex049. Rheumatology (Oxford). 2018. PMID: 28431162

7

Erythropoiesis-stimulating agents in sickle cell anaemia.

Han J, Zhou J, Kondragunta V, Zhang X, Molokie RE, Gowhari M, Hassan J, Jain S, Calip GS, Gordeuk VR, Saraf SL. Han J, et al. Among authors: calip gs. Br J Haematol. 2018 Aug;182(4):602-605. doi: 10.1111/bjh.14846. Epub 2017 Jul 27. Br J Haematol. 2018. PMID: 28748552 Free PMC article. No abstract available.

8

Characterization of opioid use in sickle cell disease.

Han J, Zhou J, Saraf SL, Gordeuk VR, Calip GS. Han J, et al. Among authors: calip gs. Pharmacoepidemiol Drug Saf. 2018 May;27(5):479-486. doi: 10.1002/pds.4291. Epub 2017 Aug 16. Pharmacoepidemiol Drug Saf. 2018. PMID: 28815799 Free PMC article.

9

Risk of Serious Bacterial Infection Associated With Tumor Necrosis Factor-Alpha Inhibitors in Children and Young Adults With Inflammatory Bowel Disease.

Lee WJ, Lee TA, Calip GS, Suda KJ, Briars L, Schumock GT. Lee WJ, et al. Among authors: calip gs. Inflamm Bowel Dis. 2018 Mar 19;24(4):883-891. doi: 10.1093/ibd/izx080. Inflamm Bowel Dis. 2018. PMID: 29562275

10

Hydroxycarbamide adherence and cumulative dose associated with hospital readmission in sickle cell disease: a 6-year population-based cohort study.

Zhou J, Han J, Nutescu EA, Gordeuk VR, Saraf SL, Calip GS. Zhou J, et al. Among authors: calip gs. Br J Haematol. 2018 Jul;182(2):259-270. doi: 10.1111/bjh.15396. Epub 2018 May 16. Br J Haematol. 2018. PMID: 29767446 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

142 results

Search Page